{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Rani Therapeutics Holdings, Inc."},"Symbol":{"label":"Symbol","value":"RANI"},"Address":{"label":"Address","value":"2051 RINGWOOD AVENUE, SAN JOSE, California, 95131, United States"},"Phone":{"label":"Phone","value":"+1 408 457-3700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing."},"CompanyUrl":{"label":"Company Url","value":"https://www.ranitherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Arvinder Dhalla","title":"Vice President-Clinical Development"},{"name":"Jacques Van Dam","title":"Vice President-Medical Affairs"},{"name":"Mir Hashim","title":"Chief Scientific Officer"},{"name":"Talat Imran","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}